Active Pharmaceutical Ingredient (API) Market, Global Outlook and Forecast 2022-2028
The Active Pharmaceutical Ingredient (API) is the part of any drug that produces its effects. Some drugs, such as combination therapies, have multiple active ingredients to treat different symptoms or act in different ways.
This report contains market size and forecasts of Active Pharmaceutical Ingredient (API) in global, including the following market information:
Global Active Pharmaceutical Ingredient (API) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Active Pharmaceutical Ingredient (API) Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Active Pharmaceutical Ingredient (API) companies in 2021 (%)
The global Active Pharmaceutical Ingredient (API) market was valued at 65040 million in 2021 and is projected to reach US$ 99720 million by 2028, at a CAGR of 6.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Anti-Infective Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Active Pharmaceutical Ingredient (API) include Teva, Mylan, DSM, Aurobindo Pharma, Aspen, Novartis, BASF, Pfizer and Huahai Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Active Pharmaceutical Ingredient (API) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Active Pharmaceutical Ingredient (API) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Active Pharmaceutical Ingredient (API) Market Segment Percentages, by Type, 2021 (%)
Global Active Pharmaceutical Ingredient (API) Market Segment Percentages, by Application, 2021 (%)
Global Active Pharmaceutical Ingredient (API) Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Active Pharmaceutical Ingredient (API) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Active Pharmaceutical Ingredient (API) revenues share in global market, 2021 (%)
Key companies Active Pharmaceutical Ingredient (API) sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Active Pharmaceutical Ingredient (API) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Active Pharmaceutical Ingredient (API) in global, including the following market information:
Global Active Pharmaceutical Ingredient (API) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Active Pharmaceutical Ingredient (API) Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Active Pharmaceutical Ingredient (API) companies in 2021 (%)
The global Active Pharmaceutical Ingredient (API) market was valued at 65040 million in 2021 and is projected to reach US$ 99720 million by 2028, at a CAGR of 6.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Anti-Infective Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Active Pharmaceutical Ingredient (API) include Teva, Mylan, DSM, Aurobindo Pharma, Aspen, Novartis, BASF, Pfizer and Huahai Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Active Pharmaceutical Ingredient (API) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Active Pharmaceutical Ingredient (API) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Active Pharmaceutical Ingredient (API) Market Segment Percentages, by Type, 2021 (%)
- Anti-Infective
- Hormonal
- Others
Global Active Pharmaceutical Ingredient (API) Market Segment Percentages, by Application, 2021 (%)
- Respiratory
- Rheumatology
- Diabetes
- Oncology
- Others
Global Active Pharmaceutical Ingredient (API) Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Active Pharmaceutical Ingredient (API) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Active Pharmaceutical Ingredient (API) revenues share in global market, 2021 (%)
Key companies Active Pharmaceutical Ingredient (API) sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Active Pharmaceutical Ingredient (API) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Teva
- Mylan
- DSM
- Aurobindo Pharma
- Aspen
- Novartis
- BASF
- Pfizer
- Huahai Pharmaceutical
- Hisun Pharmaceutical
- Sun Pharmaceutical Industries
- Zhejiang Medicine
- Dr. Reddy’s Laboratories
- Zhejiang NHU
- Bayer
- NCPC
- AbbVie
- Shandong Xinhua Pharmaceutical
- Northeast Pharm
- Harbin Pharmaceutical
- LKPC
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Active Pharmaceutical Ingredient (API) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Active Pharmaceutical Ingredient (API) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT (API) OVERALL MARKET SIZE
2.1 Global Active Pharmaceutical Ingredient (API) Market Size: 2021 VS 2028
2.2 Global Active Pharmaceutical Ingredient (API) Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Active Pharmaceutical Ingredient (API) Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Active Pharmaceutical Ingredient (API) Players in Global Market
3.2 Top Global Active Pharmaceutical Ingredient (API) Companies Ranked by Revenue
3.3 Global Active Pharmaceutical Ingredient (API) Revenue by Companies
3.4 Global Active Pharmaceutical Ingredient (API) Sales by Companies
3.5 Global Active Pharmaceutical Ingredient (API) Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Active Pharmaceutical Ingredient (API) Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Active Pharmaceutical Ingredient (API) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Active Pharmaceutical Ingredient (API) Players in Global Market
3.8.1 List of Global Tier 1 Active Pharmaceutical Ingredient (API) Companies
3.8.2 List of Global Tier 2 and Tier 3 Active Pharmaceutical Ingredient (API) Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Active Pharmaceutical Ingredient (API) Market Size Markets, 2021 & 2028
4.1.2 Anti-Infective
4.1.3 Hormonal
4.1.4 Others
4.2 By Type - Global Active Pharmaceutical Ingredient (API) Revenue & Forecasts
4.2.1 By Type - Global Active Pharmaceutical Ingredient (API) Revenue, 2017-2022
4.2.2 By Type - Global Active Pharmaceutical Ingredient (API) Revenue, 2023-2028
4.2.3 By Type - Global Active Pharmaceutical Ingredient (API) Revenue Market Share, 2017-2028
4.3 By Type - Global Active Pharmaceutical Ingredient (API) Sales & Forecasts
4.3.1 By Type - Global Active Pharmaceutical Ingredient (API) Sales, 2017-2022
4.3.2 By Type - Global Active Pharmaceutical Ingredient (API) Sales, 2023-2028
4.3.3 By Type - Global Active Pharmaceutical Ingredient (API) Sales Market Share, 2017-2028
4.4 By Type - Global Active Pharmaceutical Ingredient (API) Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Active Pharmaceutical Ingredient (API) Market Size, 2021 & 2028
5.1.2 Respiratory
5.1.3 Rheumatology
5.1.4 Diabetes
5.1.5 Oncology
5.1.6 Others
5.2 By Application - Global Active Pharmaceutical Ingredient (API) Revenue & Forecasts
5.2.1 By Application - Global Active Pharmaceutical Ingredient (API) Revenue, 2017-2022
5.2.2 By Application - Global Active Pharmaceutical Ingredient (API) Revenue, 2023-2028
5.2.3 By Application - Global Active Pharmaceutical Ingredient (API) Revenue Market Share, 2017-2028
5.3 By Application - Global Active Pharmaceutical Ingredient (API) Sales & Forecasts
5.3.1 By Application - Global Active Pharmaceutical Ingredient (API) Sales, 2017-2022
5.3.2 By Application - Global Active Pharmaceutical Ingredient (API) Sales, 2023-2028
5.3.3 By Application - Global Active Pharmaceutical Ingredient (API) Sales Market Share, 2017-2028
5.4 By Application - Global Active Pharmaceutical Ingredient (API) Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Active Pharmaceutical Ingredient (API) Market Size, 2021 & 2028
6.2 By Region - Global Active Pharmaceutical Ingredient (API) Revenue & Forecasts
6.2.1 By Region - Global Active Pharmaceutical Ingredient (API) Revenue, 2017-2022
6.2.2 By Region - Global Active Pharmaceutical Ingredient (API) Revenue, 2023-2028
6.2.3 By Region - Global Active Pharmaceutical Ingredient (API) Revenue Market Share, 2017-2028
6.3 By Region - Global Active Pharmaceutical Ingredient (API) Sales & Forecasts
6.3.1 By Region - Global Active Pharmaceutical Ingredient (API) Sales, 2017-2022
6.3.2 By Region - Global Active Pharmaceutical Ingredient (API) Sales, 2023-2028
6.3.3 By Region - Global Active Pharmaceutical Ingredient (API) Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Active Pharmaceutical Ingredient (API) Revenue, 2017-2028
6.4.2 By Country - North America Active Pharmaceutical Ingredient (API) Sales, 2017-2028
6.4.3 US Active Pharmaceutical Ingredient (API) Market Size, 2017-2028
6.4.4 Canada Active Pharmaceutical Ingredient (API) Market Size, 2017-2028
6.4.5 Mexico Active Pharmaceutical Ingredient (API) Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Active Pharmaceutical Ingredient (API) Revenue, 2017-2028
6.5.2 By Country - Europe Active Pharmaceutical Ingredient (API) Sales, 2017-2028
6.5.3 Germany Active Pharmaceutical Ingredient (API) Market Size, 2017-2028
6.5.4 France Active Pharmaceutical Ingredient (API) Market Size, 2017-2028
6.5.5 U.K. Active Pharmaceutical Ingredient (API) Market Size, 2017-2028
6.5.6 Italy Active Pharmaceutical Ingredient (API) Market Size, 2017-2028
6.5.7 Russia Active Pharmaceutical Ingredient (API) Market Size, 2017-2028
6.5.8 Nordic Countries Active Pharmaceutical Ingredient (API) Market Size, 2017-2028
6.5.9 Benelux Active Pharmaceutical Ingredient (API) Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Active Pharmaceutical Ingredient (API) Revenue, 2017-2028
6.6.2 By Region - Asia Active Pharmaceutical Ingredient (API) Sales, 2017-2028
6.6.3 China Active Pharmaceutical Ingredient (API) Market Size, 2017-2028
6.6.4 Japan Active Pharmaceutical Ingredient (API) Market Size, 2017-2028
6.6.5 South Korea Active Pharmaceutical Ingredient (API) Market Size, 2017-2028
6.6.6 Southeast Asia Active Pharmaceutical Ingredient (API) Market Size, 2017-2028
6.6.7 India Active Pharmaceutical Ingredient (API) Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Active Pharmaceutical Ingredient (API) Revenue, 2017-2028
6.7.2 By Country - South America Active Pharmaceutical Ingredient (API) Sales, 2017-2028
6.7.3 Brazil Active Pharmaceutical Ingredient (API) Market Size, 2017-2028
6.7.4 Argentina Active Pharmaceutical Ingredient (API) Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Active Pharmaceutical Ingredient (API) Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Active Pharmaceutical Ingredient (API) Sales, 2017-2028
6.8.3 Turkey Active Pharmaceutical Ingredient (API) Market Size, 2017-2028
6.8.4 Israel Active Pharmaceutical Ingredient (API) Market Size, 2017-2028
6.8.5 Saudi Arabia Active Pharmaceutical Ingredient (API) Market Size, 2017-2028
6.8.6 UAE Active Pharmaceutical Ingredient (API) Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Teva
7.1.1 Teva Corporate Summary
7.1.2 Teva Business Overview
7.1.3 Teva Active Pharmaceutical Ingredient (API) Major Product Offerings
7.1.4 Teva Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2017-2022)
7.1.5 Teva Key News
7.2 Mylan
7.2.1 Mylan Corporate Summary
7.2.2 Mylan Business Overview
7.2.3 Mylan Active Pharmaceutical Ingredient (API) Major Product Offerings
7.2.4 Mylan Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2017-2022)
7.2.5 Mylan Key News
7.3 DSM
7.3.1 DSM Corporate Summary
7.3.2 DSM Business Overview
7.3.3 DSM Active Pharmaceutical Ingredient (API) Major Product Offerings
7.3.4 DSM Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2017-2022)
7.3.5 DSM Key News
7.4 Aurobindo Pharma
7.4.1 Aurobindo Pharma Corporate Summary
7.4.2 Aurobindo Pharma Business Overview
7.4.3 Aurobindo Pharma Active Pharmaceutical Ingredient (API) Major Product Offerings
7.4.4 Aurobindo Pharma Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2017-2022)
7.4.5 Aurobindo Pharma Key News
7.5 Aspen
7.5.1 Aspen Corporate Summary
7.5.2 Aspen Business Overview
7.5.3 Aspen Active Pharmaceutical Ingredient (API) Major Product Offerings
7.5.4 Aspen Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2017-2022)
7.5.5 Aspen Key News
7.6 Novartis
7.6.1 Novartis Corporate Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Active Pharmaceutical Ingredient (API) Major Product Offerings
7.6.4 Novartis Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2017-2022)
7.6.5 Novartis Key News
7.7 BASF
7.7.1 BASF Corporate Summary
7.7.2 BASF Business Overview
7.7.3 BASF Active Pharmaceutical Ingredient (API) Major Product Offerings
7.7.4 BASF Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2017-2022)
7.7.5 BASF Key News
7.8 Pfizer
7.8.1 Pfizer Corporate Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Active Pharmaceutical Ingredient (API) Major Product Offerings
7.8.4 Pfizer Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2017-2022)
7.8.5 Pfizer Key News
7.9 Huahai Pharmaceutical
7.9.1 Huahai Pharmaceutical Corporate Summary
7.9.2 Huahai Pharmaceutical Business Overview
7.9.3 Huahai Pharmaceutical Active Pharmaceutical Ingredient (API) Major Product Offerings
7.9.4 Huahai Pharmaceutical Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2017-2022)
7.9.5 Huahai Pharmaceutical Key News
7.10 Hisun Pharmaceutical
7.10.1 Hisun Pharmaceutical Corporate Summary
7.10.2 Hisun Pharmaceutical Business Overview
7.10.3 Hisun Pharmaceutical Active Pharmaceutical Ingredient (API) Major Product Offerings
7.10.4 Hisun Pharmaceutical Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2017-2022)
7.10.5 Hisun Pharmaceutical Key News
7.11 Sun Pharmaceutical Industries
7.11.1 Sun Pharmaceutical Industries Corporate Summary
7.11.2 Sun Pharmaceutical Industries Active Pharmaceutical Ingredient (API) Business Overview
7.11.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredient (API) Major Product Offerings
7.11.4 Sun Pharmaceutical Industries Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2017-2022)
7.11.5 Sun Pharmaceutical Industries Key News
7.12 Zhejiang Medicine
7.12.1 Zhejiang Medicine Corporate Summary
7.12.2 Zhejiang Medicine Active Pharmaceutical Ingredient (API) Business Overview
7.12.3 Zhejiang Medicine Active Pharmaceutical Ingredient (API) Major Product Offerings
7.12.4 Zhejiang Medicine Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2017-2022)
7.12.5 Zhejiang Medicine Key News
7.13 Dr. Reddy’s Laboratories
7.13.1 Dr. Reddy’s Laboratories Corporate Summary
7.13.2 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient (API) Business Overview
7.13.3 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient (API) Major Product Offerings
7.13.4 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2017-2022)
7.13.5 Dr. Reddy’s Laboratories Key News
7.14 Zhejiang NHU
7.14.1 Zhejiang NHU Corporate Summary
7.14.2 Zhejiang NHU Business Overview
7.14.3 Zhejiang NHU Active Pharmaceutical Ingredient (API) Major Product Offerings
7.14.4 Zhejiang NHU Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2017-2022)
7.14.5 Zhejiang NHU Key News
7.15 Bayer
7.15.1 Bayer Corporate Summary
7.15.2 Bayer Business Overview
7.15.3 Bayer Active Pharmaceutical Ingredient (API) Major Product Offerings
7.15.4 Bayer Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2017-2022)
7.15.5 Bayer Key News
7.16 NCPC
7.16.1 NCPC Corporate Summary
7.16.2 NCPC Business Overview
7.16.3 NCPC Active Pharmaceutical Ingredient (API) Major Product Offerings
7.16.4 NCPC Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2017-2022)
7.16.5 NCPC Key News
7.17 AbbVie
7.17.1 AbbVie Corporate Summary
7.17.2 AbbVie Business Overview
7.17.3 AbbVie Active Pharmaceutical Ingredient (API) Major Product Offerings
7.17.4 AbbVie Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2017-2022)
7.17.5 AbbVie Key News
7.18 Shandong Xinhua Pharmaceutical
7.18.1 Shandong Xinhua Pharmaceutical Corporate Summary
7.18.2 Shandong Xinhua Pharmaceutical Business Overview
7.18.3 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient (API) Major Product Offerings
7.18.4 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2017-2022)
7.18.5 Shandong Xinhua Pharmaceutical Key News
7.19 Northeast Pharm
7.19.1 Northeast Pharm Corporate Summary
7.19.2 Northeast Pharm Business Overview
7.19.3 Northeast Pharm Active Pharmaceutical Ingredient (API) Major Product Offerings
7.19.4 Northeast Pharm Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2017-2022)
7.19.5 Northeast Pharm Key News
7.20 Harbin Pharmaceutical
7.20.1 Harbin Pharmaceutical Corporate Summary
7.20.2 Harbin Pharmaceutical Business Overview
7.20.3 Harbin Pharmaceutical Active Pharmaceutical Ingredient (API) Major Product Offerings
7.20.4 Harbin Pharmaceutical Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2017-2022)
7.20.5 Harbin Pharmaceutical Key News
7.21 LKPC
7.21.1 LKPC Corporate Summary
7.21.2 LKPC Business Overview
7.21.3 LKPC Active Pharmaceutical Ingredient (API) Major Product Offerings
7.21.4 LKPC Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2017-2022)
7.21.5 LKPC Key News
8 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT (API) PRODUCTION CAPACITY, ANALYSIS
8.1 Global Active Pharmaceutical Ingredient (API) Production Capacity, 2017-2028
8.2 Active Pharmaceutical Ingredient (API) Production Capacity of Key Manufacturers in Global Market
8.3 Global Active Pharmaceutical Ingredient (API) Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 ACTIVE PHARMACEUTICAL INGREDIENT (API) SUPPLY CHAIN ANALYSIS
10.1 Active Pharmaceutical Ingredient (API) Industry Value Chain
10.2 Active Pharmaceutical Ingredient (API) Upstream Market
10.3 Active Pharmaceutical Ingredient (API) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Active Pharmaceutical Ingredient (API) Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Active Pharmaceutical Ingredient (API) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Active Pharmaceutical Ingredient (API) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT (API) OVERALL MARKET SIZE
2.1 Global Active Pharmaceutical Ingredient (API) Market Size: 2021 VS 2028
2.2 Global Active Pharmaceutical Ingredient (API) Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Active Pharmaceutical Ingredient (API) Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Active Pharmaceutical Ingredient (API) Players in Global Market
3.2 Top Global Active Pharmaceutical Ingredient (API) Companies Ranked by Revenue
3.3 Global Active Pharmaceutical Ingredient (API) Revenue by Companies
3.4 Global Active Pharmaceutical Ingredient (API) Sales by Companies
3.5 Global Active Pharmaceutical Ingredient (API) Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Active Pharmaceutical Ingredient (API) Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Active Pharmaceutical Ingredient (API) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Active Pharmaceutical Ingredient (API) Players in Global Market
3.8.1 List of Global Tier 1 Active Pharmaceutical Ingredient (API) Companies
3.8.2 List of Global Tier 2 and Tier 3 Active Pharmaceutical Ingredient (API) Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Active Pharmaceutical Ingredient (API) Market Size Markets, 2021 & 2028
4.1.2 Anti-Infective
4.1.3 Hormonal
4.1.4 Others
4.2 By Type - Global Active Pharmaceutical Ingredient (API) Revenue & Forecasts
4.2.1 By Type - Global Active Pharmaceutical Ingredient (API) Revenue, 2017-2022
4.2.2 By Type - Global Active Pharmaceutical Ingredient (API) Revenue, 2023-2028
4.2.3 By Type - Global Active Pharmaceutical Ingredient (API) Revenue Market Share, 2017-2028
4.3 By Type - Global Active Pharmaceutical Ingredient (API) Sales & Forecasts
4.3.1 By Type - Global Active Pharmaceutical Ingredient (API) Sales, 2017-2022
4.3.2 By Type - Global Active Pharmaceutical Ingredient (API) Sales, 2023-2028
4.3.3 By Type - Global Active Pharmaceutical Ingredient (API) Sales Market Share, 2017-2028
4.4 By Type - Global Active Pharmaceutical Ingredient (API) Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Active Pharmaceutical Ingredient (API) Market Size, 2021 & 2028
5.1.2 Respiratory
5.1.3 Rheumatology
5.1.4 Diabetes
5.1.5 Oncology
5.1.6 Others
5.2 By Application - Global Active Pharmaceutical Ingredient (API) Revenue & Forecasts
5.2.1 By Application - Global Active Pharmaceutical Ingredient (API) Revenue, 2017-2022
5.2.2 By Application - Global Active Pharmaceutical Ingredient (API) Revenue, 2023-2028
5.2.3 By Application - Global Active Pharmaceutical Ingredient (API) Revenue Market Share, 2017-2028
5.3 By Application - Global Active Pharmaceutical Ingredient (API) Sales & Forecasts
5.3.1 By Application - Global Active Pharmaceutical Ingredient (API) Sales, 2017-2022
5.3.2 By Application - Global Active Pharmaceutical Ingredient (API) Sales, 2023-2028
5.3.3 By Application - Global Active Pharmaceutical Ingredient (API) Sales Market Share, 2017-2028
5.4 By Application - Global Active Pharmaceutical Ingredient (API) Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Active Pharmaceutical Ingredient (API) Market Size, 2021 & 2028
6.2 By Region - Global Active Pharmaceutical Ingredient (API) Revenue & Forecasts
6.2.1 By Region - Global Active Pharmaceutical Ingredient (API) Revenue, 2017-2022
6.2.2 By Region - Global Active Pharmaceutical Ingredient (API) Revenue, 2023-2028
6.2.3 By Region - Global Active Pharmaceutical Ingredient (API) Revenue Market Share, 2017-2028
6.3 By Region - Global Active Pharmaceutical Ingredient (API) Sales & Forecasts
6.3.1 By Region - Global Active Pharmaceutical Ingredient (API) Sales, 2017-2022
6.3.2 By Region - Global Active Pharmaceutical Ingredient (API) Sales, 2023-2028
6.3.3 By Region - Global Active Pharmaceutical Ingredient (API) Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Active Pharmaceutical Ingredient (API) Revenue, 2017-2028
6.4.2 By Country - North America Active Pharmaceutical Ingredient (API) Sales, 2017-2028
6.4.3 US Active Pharmaceutical Ingredient (API) Market Size, 2017-2028
6.4.4 Canada Active Pharmaceutical Ingredient (API) Market Size, 2017-2028
6.4.5 Mexico Active Pharmaceutical Ingredient (API) Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Active Pharmaceutical Ingredient (API) Revenue, 2017-2028
6.5.2 By Country - Europe Active Pharmaceutical Ingredient (API) Sales, 2017-2028
6.5.3 Germany Active Pharmaceutical Ingredient (API) Market Size, 2017-2028
6.5.4 France Active Pharmaceutical Ingredient (API) Market Size, 2017-2028
6.5.5 U.K. Active Pharmaceutical Ingredient (API) Market Size, 2017-2028
6.5.6 Italy Active Pharmaceutical Ingredient (API) Market Size, 2017-2028
6.5.7 Russia Active Pharmaceutical Ingredient (API) Market Size, 2017-2028
6.5.8 Nordic Countries Active Pharmaceutical Ingredient (API) Market Size, 2017-2028
6.5.9 Benelux Active Pharmaceutical Ingredient (API) Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Active Pharmaceutical Ingredient (API) Revenue, 2017-2028
6.6.2 By Region - Asia Active Pharmaceutical Ingredient (API) Sales, 2017-2028
6.6.3 China Active Pharmaceutical Ingredient (API) Market Size, 2017-2028
6.6.4 Japan Active Pharmaceutical Ingredient (API) Market Size, 2017-2028
6.6.5 South Korea Active Pharmaceutical Ingredient (API) Market Size, 2017-2028
6.6.6 Southeast Asia Active Pharmaceutical Ingredient (API) Market Size, 2017-2028
6.6.7 India Active Pharmaceutical Ingredient (API) Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Active Pharmaceutical Ingredient (API) Revenue, 2017-2028
6.7.2 By Country - South America Active Pharmaceutical Ingredient (API) Sales, 2017-2028
6.7.3 Brazil Active Pharmaceutical Ingredient (API) Market Size, 2017-2028
6.7.4 Argentina Active Pharmaceutical Ingredient (API) Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Active Pharmaceutical Ingredient (API) Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Active Pharmaceutical Ingredient (API) Sales, 2017-2028
6.8.3 Turkey Active Pharmaceutical Ingredient (API) Market Size, 2017-2028
6.8.4 Israel Active Pharmaceutical Ingredient (API) Market Size, 2017-2028
6.8.5 Saudi Arabia Active Pharmaceutical Ingredient (API) Market Size, 2017-2028
6.8.6 UAE Active Pharmaceutical Ingredient (API) Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Teva
7.1.1 Teva Corporate Summary
7.1.2 Teva Business Overview
7.1.3 Teva Active Pharmaceutical Ingredient (API) Major Product Offerings
7.1.4 Teva Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2017-2022)
7.1.5 Teva Key News
7.2 Mylan
7.2.1 Mylan Corporate Summary
7.2.2 Mylan Business Overview
7.2.3 Mylan Active Pharmaceutical Ingredient (API) Major Product Offerings
7.2.4 Mylan Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2017-2022)
7.2.5 Mylan Key News
7.3 DSM
7.3.1 DSM Corporate Summary
7.3.2 DSM Business Overview
7.3.3 DSM Active Pharmaceutical Ingredient (API) Major Product Offerings
7.3.4 DSM Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2017-2022)
7.3.5 DSM Key News
7.4 Aurobindo Pharma
7.4.1 Aurobindo Pharma Corporate Summary
7.4.2 Aurobindo Pharma Business Overview
7.4.3 Aurobindo Pharma Active Pharmaceutical Ingredient (API) Major Product Offerings
7.4.4 Aurobindo Pharma Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2017-2022)
7.4.5 Aurobindo Pharma Key News
7.5 Aspen
7.5.1 Aspen Corporate Summary
7.5.2 Aspen Business Overview
7.5.3 Aspen Active Pharmaceutical Ingredient (API) Major Product Offerings
7.5.4 Aspen Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2017-2022)
7.5.5 Aspen Key News
7.6 Novartis
7.6.1 Novartis Corporate Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Active Pharmaceutical Ingredient (API) Major Product Offerings
7.6.4 Novartis Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2017-2022)
7.6.5 Novartis Key News
7.7 BASF
7.7.1 BASF Corporate Summary
7.7.2 BASF Business Overview
7.7.3 BASF Active Pharmaceutical Ingredient (API) Major Product Offerings
7.7.4 BASF Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2017-2022)
7.7.5 BASF Key News
7.8 Pfizer
7.8.1 Pfizer Corporate Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Active Pharmaceutical Ingredient (API) Major Product Offerings
7.8.4 Pfizer Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2017-2022)
7.8.5 Pfizer Key News
7.9 Huahai Pharmaceutical
7.9.1 Huahai Pharmaceutical Corporate Summary
7.9.2 Huahai Pharmaceutical Business Overview
7.9.3 Huahai Pharmaceutical Active Pharmaceutical Ingredient (API) Major Product Offerings
7.9.4 Huahai Pharmaceutical Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2017-2022)
7.9.5 Huahai Pharmaceutical Key News
7.10 Hisun Pharmaceutical
7.10.1 Hisun Pharmaceutical Corporate Summary
7.10.2 Hisun Pharmaceutical Business Overview
7.10.3 Hisun Pharmaceutical Active Pharmaceutical Ingredient (API) Major Product Offerings
7.10.4 Hisun Pharmaceutical Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2017-2022)
7.10.5 Hisun Pharmaceutical Key News
7.11 Sun Pharmaceutical Industries
7.11.1 Sun Pharmaceutical Industries Corporate Summary
7.11.2 Sun Pharmaceutical Industries Active Pharmaceutical Ingredient (API) Business Overview
7.11.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredient (API) Major Product Offerings
7.11.4 Sun Pharmaceutical Industries Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2017-2022)
7.11.5 Sun Pharmaceutical Industries Key News
7.12 Zhejiang Medicine
7.12.1 Zhejiang Medicine Corporate Summary
7.12.2 Zhejiang Medicine Active Pharmaceutical Ingredient (API) Business Overview
7.12.3 Zhejiang Medicine Active Pharmaceutical Ingredient (API) Major Product Offerings
7.12.4 Zhejiang Medicine Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2017-2022)
7.12.5 Zhejiang Medicine Key News
7.13 Dr. Reddy’s Laboratories
7.13.1 Dr. Reddy’s Laboratories Corporate Summary
7.13.2 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient (API) Business Overview
7.13.3 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient (API) Major Product Offerings
7.13.4 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2017-2022)
7.13.5 Dr. Reddy’s Laboratories Key News
7.14 Zhejiang NHU
7.14.1 Zhejiang NHU Corporate Summary
7.14.2 Zhejiang NHU Business Overview
7.14.3 Zhejiang NHU Active Pharmaceutical Ingredient (API) Major Product Offerings
7.14.4 Zhejiang NHU Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2017-2022)
7.14.5 Zhejiang NHU Key News
7.15 Bayer
7.15.1 Bayer Corporate Summary
7.15.2 Bayer Business Overview
7.15.3 Bayer Active Pharmaceutical Ingredient (API) Major Product Offerings
7.15.4 Bayer Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2017-2022)
7.15.5 Bayer Key News
7.16 NCPC
7.16.1 NCPC Corporate Summary
7.16.2 NCPC Business Overview
7.16.3 NCPC Active Pharmaceutical Ingredient (API) Major Product Offerings
7.16.4 NCPC Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2017-2022)
7.16.5 NCPC Key News
7.17 AbbVie
7.17.1 AbbVie Corporate Summary
7.17.2 AbbVie Business Overview
7.17.3 AbbVie Active Pharmaceutical Ingredient (API) Major Product Offerings
7.17.4 AbbVie Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2017-2022)
7.17.5 AbbVie Key News
7.18 Shandong Xinhua Pharmaceutical
7.18.1 Shandong Xinhua Pharmaceutical Corporate Summary
7.18.2 Shandong Xinhua Pharmaceutical Business Overview
7.18.3 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient (API) Major Product Offerings
7.18.4 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2017-2022)
7.18.5 Shandong Xinhua Pharmaceutical Key News
7.19 Northeast Pharm
7.19.1 Northeast Pharm Corporate Summary
7.19.2 Northeast Pharm Business Overview
7.19.3 Northeast Pharm Active Pharmaceutical Ingredient (API) Major Product Offerings
7.19.4 Northeast Pharm Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2017-2022)
7.19.5 Northeast Pharm Key News
7.20 Harbin Pharmaceutical
7.20.1 Harbin Pharmaceutical Corporate Summary
7.20.2 Harbin Pharmaceutical Business Overview
7.20.3 Harbin Pharmaceutical Active Pharmaceutical Ingredient (API) Major Product Offerings
7.20.4 Harbin Pharmaceutical Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2017-2022)
7.20.5 Harbin Pharmaceutical Key News
7.21 LKPC
7.21.1 LKPC Corporate Summary
7.21.2 LKPC Business Overview
7.21.3 LKPC Active Pharmaceutical Ingredient (API) Major Product Offerings
7.21.4 LKPC Active Pharmaceutical Ingredient (API) Sales and Revenue in Global (2017-2022)
7.21.5 LKPC Key News
8 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENT (API) PRODUCTION CAPACITY, ANALYSIS
8.1 Global Active Pharmaceutical Ingredient (API) Production Capacity, 2017-2028
8.2 Active Pharmaceutical Ingredient (API) Production Capacity of Key Manufacturers in Global Market
8.3 Global Active Pharmaceutical Ingredient (API) Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 ACTIVE PHARMACEUTICAL INGREDIENT (API) SUPPLY CHAIN ANALYSIS
10.1 Active Pharmaceutical Ingredient (API) Industry Value Chain
10.2 Active Pharmaceutical Ingredient (API) Upstream Market
10.3 Active Pharmaceutical Ingredient (API) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Active Pharmaceutical Ingredient (API) Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Active Pharmaceutical Ingredient (API) in Global Market
Table 2. Top Active Pharmaceutical Ingredient (API) Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Active Pharmaceutical Ingredient (API) Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Active Pharmaceutical Ingredient (API) Revenue Share by Companies, 2017-2022
Table 5. Global Active Pharmaceutical Ingredient (API) Sales by Companies, (K Units), 2017-2022
Table 6. Global Active Pharmaceutical Ingredient (API) Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Active Pharmaceutical Ingredient (API) Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Active Pharmaceutical Ingredient (API) Product Type
Table 9. List of Global Tier 1 Active Pharmaceutical Ingredient (API) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Active Pharmaceutical Ingredient (API) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Active Pharmaceutical Ingredient (API) Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Active Pharmaceutical Ingredient (API) Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Active Pharmaceutical Ingredient (API) Sales (K Units), 2017-2022
Table 15. By Type - Global Active Pharmaceutical Ingredient (API) Sales (K Units), 2023-2028
Table 16. By Application – Global Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Active Pharmaceutical Ingredient (API) Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Active Pharmaceutical Ingredient (API) Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Active Pharmaceutical Ingredient (API) Sales (K Units), 2017-2022
Table 20. By Application - Global Active Pharmaceutical Ingredient (API) Sales (K Units), 2023-2028
Table 21. By Region – Global Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Active Pharmaceutical Ingredient (API) Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Active Pharmaceutical Ingredient (API) Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Active Pharmaceutical Ingredient (API) Sales (K Units), 2017-2022
Table 25. By Region - Global Active Pharmaceutical Ingredient (API) Sales (K Units), 2023-2028
Table 26. By Country - North America Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Active Pharmaceutical Ingredient (API) Sales, (K Units), 2017-2022
Table 29. By Country - North America Active Pharmaceutical Ingredient (API) Sales, (K Units), 2023-2028
Table 30. By Country - Europe Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Active Pharmaceutical Ingredient (API) Sales, (K Units), 2017-2022
Table 33. By Country - Europe Active Pharmaceutical Ingredient (API) Sales, (K Units), 2023-2028
Table 34. By Region - Asia Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Active Pharmaceutical Ingredient (API) Sales, (K Units), 2017-2022
Table 37. By Region - Asia Active Pharmaceutical Ingredient (API) Sales, (K Units), 2023-2028
Table 38. By Country - South America Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Active Pharmaceutical Ingredient (API) Sales, (K Units), 2017-2022
Table 41. By Country - South America Active Pharmaceutical Ingredient (API) Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Active Pharmaceutical Ingredient (API) Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Active Pharmaceutical Ingredient (API) Sales, (K Units), 2023-2028
Table 46. Teva Corporate Summary
Table 47. Teva Active Pharmaceutical Ingredient (API) Product Offerings
Table 48. Teva Active Pharmaceutical Ingredient (API) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Mylan Corporate Summary
Table 50. Mylan Active Pharmaceutical Ingredient (API) Product Offerings
Table 51. Mylan Active Pharmaceutical Ingredient (API) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. DSM Corporate Summary
Table 53. DSM Active Pharmaceutical Ingredient (API) Product Offerings
Table 54. DSM Active Pharmaceutical Ingredient (API) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Aurobindo Pharma Corporate Summary
Table 56. Aurobindo Pharma Active Pharmaceutical Ingredient (API) Product Offerings
Table 57. Aurobindo Pharma Active Pharmaceutical Ingredient (API) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Aspen Corporate Summary
Table 59. Aspen Active Pharmaceutical Ingredient (API) Product Offerings
Table 60. Aspen Active Pharmaceutical Ingredient (API) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Novartis Corporate Summary
Table 62. Novartis Active Pharmaceutical Ingredient (API) Product Offerings
Table 63. Novartis Active Pharmaceutical Ingredient (API) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. BASF Corporate Summary
Table 65. BASF Active Pharmaceutical Ingredient (API) Product Offerings
Table 66. BASF Active Pharmaceutical Ingredient (API) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Pfizer Corporate Summary
Table 68. Pfizer Active Pharmaceutical Ingredient (API) Product Offerings
Table 69. Pfizer Active Pharmaceutical Ingredient (API) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Huahai Pharmaceutical Corporate Summary
Table 71. Huahai Pharmaceutical Active Pharmaceutical Ingredient (API) Product Offerings
Table 72. Huahai Pharmaceutical Active Pharmaceutical Ingredient (API) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Hisun Pharmaceutical Corporate Summary
Table 74. Hisun Pharmaceutical Active Pharmaceutical Ingredient (API) Product Offerings
Table 75. Hisun Pharmaceutical Active Pharmaceutical Ingredient (API) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Sun Pharmaceutical Industries Corporate Summary
Table 77. Sun Pharmaceutical Industries Active Pharmaceutical Ingredient (API) Product Offerings
Table 78. Sun Pharmaceutical Industries Active Pharmaceutical Ingredient (API) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. Zhejiang Medicine Corporate Summary
Table 80. Zhejiang Medicine Active Pharmaceutical Ingredient (API) Product Offerings
Table 81. Zhejiang Medicine Active Pharmaceutical Ingredient (API) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 82. Dr. Reddy’s Laboratories Corporate Summary
Table 83. Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient (API) Product Offerings
Table 84. Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient (API) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 85. Zhejiang NHU Corporate Summary
Table 86. Zhejiang NHU Active Pharmaceutical Ingredient (API) Product Offerings
Table 87. Zhejiang NHU Active Pharmaceutical Ingredient (API) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 88. Bayer Corporate Summary
Table 89. Bayer Active Pharmaceutical Ingredient (API) Product Offerings
Table 90. Bayer Active Pharmaceutical Ingredient (API) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 91. NCPC Corporate Summary
Table 92. NCPC Active Pharmaceutical Ingredient (API) Product Offerings
Table 93. NCPC Active Pharmaceutical Ingredient (API) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 94. AbbVie Corporate Summary
Table 95. AbbVie Active Pharmaceutical Ingredient (API) Product Offerings
Table 96. AbbVie Active Pharmaceutical Ingredient (API) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 97. Shandong Xinhua Pharmaceutical Corporate Summary
Table 98. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient (API) Product Offerings
Table 99. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient (API) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 100. Northeast Pharm Corporate Summary
Table 101. Northeast Pharm Active Pharmaceutical Ingredient (API) Product Offerings
Table 102. Northeast Pharm Active Pharmaceutical Ingredient (API) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 103. Harbin Pharmaceutical Corporate Summary
Table 104. Harbin Pharmaceutical Active Pharmaceutical Ingredient (API) Product Offerings
Table 105. Harbin Pharmaceutical Active Pharmaceutical Ingredient (API) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 106. LKPC Corporate Summary
Table 107. LKPC Active Pharmaceutical Ingredient (API) Product Offerings
Table 108. LKPC Active Pharmaceutical Ingredient (API) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 109. Active Pharmaceutical Ingredient (API) Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 110. Global Active Pharmaceutical Ingredient (API) Capacity Market Share of Key Manufacturers, 2020-2022
Table 111. Global Active Pharmaceutical Ingredient (API) Production by Region, 2017-2022 (K Units)
Table 112. Global Active Pharmaceutical Ingredient (API) Production by Region, 2023-2028 (K Units)
Table 113. Active Pharmaceutical Ingredient (API) Market Opportunities & Trends in Global Market
Table 114. Active Pharmaceutical Ingredient (API) Market Drivers in Global Market
Table 115. Active Pharmaceutical Ingredient (API) Market Restraints in Global Market
Table 116. Active Pharmaceutical Ingredient (API) Raw Materials
Table 117. Active Pharmaceutical Ingredient (API) Raw Materials Suppliers in Global Market
Table 118. Typical Active Pharmaceutical Ingredient (API) Downstream
Table 119. Active Pharmaceutical Ingredient (API) Downstream Clients in Global Market
Table 120. Active Pharmaceutical Ingredient (API) Distributors and Sales Agents in Global Market
Table 1. Key Players of Active Pharmaceutical Ingredient (API) in Global Market
Table 2. Top Active Pharmaceutical Ingredient (API) Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Active Pharmaceutical Ingredient (API) Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Active Pharmaceutical Ingredient (API) Revenue Share by Companies, 2017-2022
Table 5. Global Active Pharmaceutical Ingredient (API) Sales by Companies, (K Units), 2017-2022
Table 6. Global Active Pharmaceutical Ingredient (API) Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Active Pharmaceutical Ingredient (API) Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Active Pharmaceutical Ingredient (API) Product Type
Table 9. List of Global Tier 1 Active Pharmaceutical Ingredient (API) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Active Pharmaceutical Ingredient (API) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Active Pharmaceutical Ingredient (API) Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Active Pharmaceutical Ingredient (API) Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Active Pharmaceutical Ingredient (API) Sales (K Units), 2017-2022
Table 15. By Type - Global Active Pharmaceutical Ingredient (API) Sales (K Units), 2023-2028
Table 16. By Application – Global Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Active Pharmaceutical Ingredient (API) Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Active Pharmaceutical Ingredient (API) Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Active Pharmaceutical Ingredient (API) Sales (K Units), 2017-2022
Table 20. By Application - Global Active Pharmaceutical Ingredient (API) Sales (K Units), 2023-2028
Table 21. By Region – Global Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Active Pharmaceutical Ingredient (API) Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Active Pharmaceutical Ingredient (API) Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Active Pharmaceutical Ingredient (API) Sales (K Units), 2017-2022
Table 25. By Region - Global Active Pharmaceutical Ingredient (API) Sales (K Units), 2023-2028
Table 26. By Country - North America Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Active Pharmaceutical Ingredient (API) Sales, (K Units), 2017-2022
Table 29. By Country - North America Active Pharmaceutical Ingredient (API) Sales, (K Units), 2023-2028
Table 30. By Country - Europe Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Active Pharmaceutical Ingredient (API) Sales, (K Units), 2017-2022
Table 33. By Country - Europe Active Pharmaceutical Ingredient (API) Sales, (K Units), 2023-2028
Table 34. By Region - Asia Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Active Pharmaceutical Ingredient (API) Sales, (K Units), 2017-2022
Table 37. By Region - Asia Active Pharmaceutical Ingredient (API) Sales, (K Units), 2023-2028
Table 38. By Country - South America Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Active Pharmaceutical Ingredient (API) Sales, (K Units), 2017-2022
Table 41. By Country - South America Active Pharmaceutical Ingredient (API) Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Active Pharmaceutical Ingredient (API) Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Active Pharmaceutical Ingredient (API) Sales, (K Units), 2023-2028
Table 46. Teva Corporate Summary
Table 47. Teva Active Pharmaceutical Ingredient (API) Product Offerings
Table 48. Teva Active Pharmaceutical Ingredient (API) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Mylan Corporate Summary
Table 50. Mylan Active Pharmaceutical Ingredient (API) Product Offerings
Table 51. Mylan Active Pharmaceutical Ingredient (API) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. DSM Corporate Summary
Table 53. DSM Active Pharmaceutical Ingredient (API) Product Offerings
Table 54. DSM Active Pharmaceutical Ingredient (API) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Aurobindo Pharma Corporate Summary
Table 56. Aurobindo Pharma Active Pharmaceutical Ingredient (API) Product Offerings
Table 57. Aurobindo Pharma Active Pharmaceutical Ingredient (API) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Aspen Corporate Summary
Table 59. Aspen Active Pharmaceutical Ingredient (API) Product Offerings
Table 60. Aspen Active Pharmaceutical Ingredient (API) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Novartis Corporate Summary
Table 62. Novartis Active Pharmaceutical Ingredient (API) Product Offerings
Table 63. Novartis Active Pharmaceutical Ingredient (API) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. BASF Corporate Summary
Table 65. BASF Active Pharmaceutical Ingredient (API) Product Offerings
Table 66. BASF Active Pharmaceutical Ingredient (API) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Pfizer Corporate Summary
Table 68. Pfizer Active Pharmaceutical Ingredient (API) Product Offerings
Table 69. Pfizer Active Pharmaceutical Ingredient (API) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Huahai Pharmaceutical Corporate Summary
Table 71. Huahai Pharmaceutical Active Pharmaceutical Ingredient (API) Product Offerings
Table 72. Huahai Pharmaceutical Active Pharmaceutical Ingredient (API) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Hisun Pharmaceutical Corporate Summary
Table 74. Hisun Pharmaceutical Active Pharmaceutical Ingredient (API) Product Offerings
Table 75. Hisun Pharmaceutical Active Pharmaceutical Ingredient (API) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Sun Pharmaceutical Industries Corporate Summary
Table 77. Sun Pharmaceutical Industries Active Pharmaceutical Ingredient (API) Product Offerings
Table 78. Sun Pharmaceutical Industries Active Pharmaceutical Ingredient (API) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. Zhejiang Medicine Corporate Summary
Table 80. Zhejiang Medicine Active Pharmaceutical Ingredient (API) Product Offerings
Table 81. Zhejiang Medicine Active Pharmaceutical Ingredient (API) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 82. Dr. Reddy’s Laboratories Corporate Summary
Table 83. Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient (API) Product Offerings
Table 84. Dr. Reddy’s Laboratories Active Pharmaceutical Ingredient (API) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 85. Zhejiang NHU Corporate Summary
Table 86. Zhejiang NHU Active Pharmaceutical Ingredient (API) Product Offerings
Table 87. Zhejiang NHU Active Pharmaceutical Ingredient (API) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 88. Bayer Corporate Summary
Table 89. Bayer Active Pharmaceutical Ingredient (API) Product Offerings
Table 90. Bayer Active Pharmaceutical Ingredient (API) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 91. NCPC Corporate Summary
Table 92. NCPC Active Pharmaceutical Ingredient (API) Product Offerings
Table 93. NCPC Active Pharmaceutical Ingredient (API) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 94. AbbVie Corporate Summary
Table 95. AbbVie Active Pharmaceutical Ingredient (API) Product Offerings
Table 96. AbbVie Active Pharmaceutical Ingredient (API) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 97. Shandong Xinhua Pharmaceutical Corporate Summary
Table 98. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient (API) Product Offerings
Table 99. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient (API) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 100. Northeast Pharm Corporate Summary
Table 101. Northeast Pharm Active Pharmaceutical Ingredient (API) Product Offerings
Table 102. Northeast Pharm Active Pharmaceutical Ingredient (API) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 103. Harbin Pharmaceutical Corporate Summary
Table 104. Harbin Pharmaceutical Active Pharmaceutical Ingredient (API) Product Offerings
Table 105. Harbin Pharmaceutical Active Pharmaceutical Ingredient (API) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 106. LKPC Corporate Summary
Table 107. LKPC Active Pharmaceutical Ingredient (API) Product Offerings
Table 108. LKPC Active Pharmaceutical Ingredient (API) Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 109. Active Pharmaceutical Ingredient (API) Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 110. Global Active Pharmaceutical Ingredient (API) Capacity Market Share of Key Manufacturers, 2020-2022
Table 111. Global Active Pharmaceutical Ingredient (API) Production by Region, 2017-2022 (K Units)
Table 112. Global Active Pharmaceutical Ingredient (API) Production by Region, 2023-2028 (K Units)
Table 113. Active Pharmaceutical Ingredient (API) Market Opportunities & Trends in Global Market
Table 114. Active Pharmaceutical Ingredient (API) Market Drivers in Global Market
Table 115. Active Pharmaceutical Ingredient (API) Market Restraints in Global Market
Table 116. Active Pharmaceutical Ingredient (API) Raw Materials
Table 117. Active Pharmaceutical Ingredient (API) Raw Materials Suppliers in Global Market
Table 118. Typical Active Pharmaceutical Ingredient (API) Downstream
Table 119. Active Pharmaceutical Ingredient (API) Downstream Clients in Global Market
Table 120. Active Pharmaceutical Ingredient (API) Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Active Pharmaceutical Ingredient (API) Segment by Type
Figure 2. Active Pharmaceutical Ingredient (API) Segment by Application
Figure 3. Global Active Pharmaceutical Ingredient (API) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Active Pharmaceutical Ingredient (API) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Active Pharmaceutical Ingredient (API) Revenue, 2017-2028 (US$, Mn)
Figure 7. Active Pharmaceutical Ingredient (API) Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Active Pharmaceutical Ingredient (API) Revenue in 2021
Figure 9. By Type - Global Active Pharmaceutical Ingredient (API) Sales Market Share, 2017-2028
Figure 10. By Type - Global Active Pharmaceutical Ingredient (API) Revenue Market Share, 2017-2028
Figure 11. By Type - Global Active Pharmaceutical Ingredient (API) Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Active Pharmaceutical Ingredient (API) Sales Market Share, 2017-2028
Figure 13. By Application - Global Active Pharmaceutical Ingredient (API) Revenue Market Share, 2017-2028
Figure 14. By Application - Global Active Pharmaceutical Ingredient (API) Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Active Pharmaceutical Ingredient (API) Sales Market Share, 2017-2028
Figure 16. By Region - Global Active Pharmaceutical Ingredient (API) Revenue Market Share, 2017-2028
Figure 17. By Country - North America Active Pharmaceutical Ingredient (API) Revenue Market Share, 2017-2028
Figure 18. By Country - North America Active Pharmaceutical Ingredient (API) Sales Market Share, 2017-2028
Figure 19. US Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Active Pharmaceutical Ingredient (API) Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Active Pharmaceutical Ingredient (API) Sales Market Share, 2017-2028
Figure 24. Germany Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2028
Figure 25. France Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Active Pharmaceutical Ingredient (API) Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Active Pharmaceutical Ingredient (API) Sales Market Share, 2017-2028
Figure 33. China Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2028
Figure 37. India Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Active Pharmaceutical Ingredient (API) Revenue Market Share, 2017-2028
Figure 39. By Country - South America Active Pharmaceutical Ingredient (API) Sales Market Share, 2017-2028
Figure 40. Brazil Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Active Pharmaceutical Ingredient (API) Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Active Pharmaceutical Ingredient (API) Sales Market Share, 2017-2028
Figure 44. Turkey Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2028
Figure 48. Global Active Pharmaceutical Ingredient (API) Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Active Pharmaceutical Ingredient (API) by Region, 2021 VS 2028
Figure 50. Active Pharmaceutical Ingredient (API) Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Active Pharmaceutical Ingredient (API) Segment by Type
Figure 2. Active Pharmaceutical Ingredient (API) Segment by Application
Figure 3. Global Active Pharmaceutical Ingredient (API) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Active Pharmaceutical Ingredient (API) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Active Pharmaceutical Ingredient (API) Revenue, 2017-2028 (US$, Mn)
Figure 7. Active Pharmaceutical Ingredient (API) Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Active Pharmaceutical Ingredient (API) Revenue in 2021
Figure 9. By Type - Global Active Pharmaceutical Ingredient (API) Sales Market Share, 2017-2028
Figure 10. By Type - Global Active Pharmaceutical Ingredient (API) Revenue Market Share, 2017-2028
Figure 11. By Type - Global Active Pharmaceutical Ingredient (API) Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Active Pharmaceutical Ingredient (API) Sales Market Share, 2017-2028
Figure 13. By Application - Global Active Pharmaceutical Ingredient (API) Revenue Market Share, 2017-2028
Figure 14. By Application - Global Active Pharmaceutical Ingredient (API) Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Active Pharmaceutical Ingredient (API) Sales Market Share, 2017-2028
Figure 16. By Region - Global Active Pharmaceutical Ingredient (API) Revenue Market Share, 2017-2028
Figure 17. By Country - North America Active Pharmaceutical Ingredient (API) Revenue Market Share, 2017-2028
Figure 18. By Country - North America Active Pharmaceutical Ingredient (API) Sales Market Share, 2017-2028
Figure 19. US Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Active Pharmaceutical Ingredient (API) Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Active Pharmaceutical Ingredient (API) Sales Market Share, 2017-2028
Figure 24. Germany Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2028
Figure 25. France Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Active Pharmaceutical Ingredient (API) Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Active Pharmaceutical Ingredient (API) Sales Market Share, 2017-2028
Figure 33. China Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2028
Figure 37. India Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Active Pharmaceutical Ingredient (API) Revenue Market Share, 2017-2028
Figure 39. By Country - South America Active Pharmaceutical Ingredient (API) Sales Market Share, 2017-2028
Figure 40. Brazil Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Active Pharmaceutical Ingredient (API) Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Active Pharmaceutical Ingredient (API) Sales Market Share, 2017-2028
Figure 44. Turkey Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Active Pharmaceutical Ingredient (API) Revenue, (US$, Mn), 2017-2028
Figure 48. Global Active Pharmaceutical Ingredient (API) Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Active Pharmaceutical Ingredient (API) by Region, 2021 VS 2028
Figure 50. Active Pharmaceutical Ingredient (API) Industry Value Chain
Figure 51. Marketing Channels
